P1677: DEFINING KEY QUALITY OF LIFE METRICS IN ACUTE MYELOID LEUKAEMIA AND HIGH RISK MYELODYSPLASTIC SYNDROME PATIENTS ENROLLED IN LARGE-SCALE UK NCRI AML TRIALS

• Pramila Krishnamurthy,
• Myrsini Gianatsi,
• Sophie Wintrich,
• Abin Thomas,
• Lynn Quek,
• Austin Kulasekararaj,
• Priyanka Mehta,
• Sreetharan Munisamy,
• Nigel Russell,
• Mike Dennis,
• Elspeth Payne,
• Ian Thomas

Affiliations

Pramila Krishnamurthy

1 King’s College Hospital, United Kingdom

Myrsini Gianatsi

2 Cardiff University, United Kingdom

Sophie Wintrich

3 MDS UK Patient Support Group, United Kingdom

Abin Thomas

2 Cardiff University, United Kingdom

Lynn Quek

4 King’s College London, United Kingdom

Austin Kulasekararaj

1 King’s College Hospital, United Kingdom

Priyanka Mehta

5 University Hospital Bristol, United Kingdom

Sreetharan Munisamy

6 Kent and Canterbury Hospital, United Kingdom

Nigel Russell

7 Guy’s Hospital, United Kingdom

Mike Dennis

8 Christie Hospital Nhs Trust, United Kingdom

Elspeth Payne

9 University College London, United Kingdom

Ian Thomas

2 Cardiff University, United Kingdom